ExodusPoint Capital Management LP Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

ExodusPoint Capital Management LP purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 66,917 shares of the exchange traded fund’s stock, valued at approximately $6,027,000. ExodusPoint Capital Management LP owned approximately 0.09% of SPDR S&P Biotech ETF at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Howard Capital Management Group LLC boosted its holdings in SPDR S&P Biotech ETF by 2.6% in the third quarter. Howard Capital Management Group LLC now owns 248,114 shares of the exchange traded fund’s stock worth $24,514,000 after purchasing an additional 6,188 shares during the last quarter. FMR LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 13.6% during the 3rd quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after buying an additional 830 shares during the period. Captrust Financial Advisors boosted its stake in shares of SPDR S&P Biotech ETF by 135.5% in the 3rd quarter. Captrust Financial Advisors now owns 18,252 shares of the exchange traded fund’s stock worth $1,803,000 after buying an additional 10,501 shares during the last quarter. Benjamin Edwards Inc. bought a new stake in shares of SPDR S&P Biotech ETF in the third quarter worth $245,000. Finally, Stifel Financial Corp increased its position in SPDR S&P Biotech ETF by 20.8% during the third quarter. Stifel Financial Corp now owns 288,109 shares of the exchange traded fund’s stock valued at $28,466,000 after acquiring an additional 49,550 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $73.66 on Friday. The stock’s 50-day simple moving average is $88.13 and its two-hundred day simple moving average is $93.17. The stock has a market capitalization of $4.65 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00. SPDR S&P Biotech ETF has a 52-week low of $73.25 and a 52-week high of $105.47.

SPDR S&P Biotech ETF Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, March 26th. Investors of record on Monday, March 24th were issued a $0.0053 dividend. The ex-dividend date of this dividend was Monday, March 24th.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.